The study analyzed that the IPF pipeline comprised of 97 therapeutic candidates, of which 15
are in Phase II stage of development. The lack of complete cure for IPF fuels
the extensive research and development for the IPF therapeutic. Various drugs
are being developed as novel and promising therapeutics for the treatment of
IPF.
Home »
Idiopathic Pulmonary Fibrosis Pipeline
,
Idiopathic Pulmonary Fibrosis Pipeline Analysis
,
IPF Pipeline
,
IPF Pipeline Analysis
» Idiopathic Pulmonary Fibrosis (IPF) Pipeline to Witness Huge R&D Investment in the Coming Years
No comments:
Post a Comment